Dongliang Song
Overview
Explore the profile of Dongliang Song including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang Q, Zhu S, Hu N, Yin S, Yang Y, Teng Y, et al.
FEBS J
. 2025 Mar;
PMID: 40029004
T7 RNA polymerase (RNAP), the preferred tool for in vitro transcription (IVT), can generate double-stranded RNA (dsRNA) by-products that elicit immune stress and pose safety concerns. By combining the molecular...
2.
Jin X, Zhu H, Chen X, Yang Y, Song D
Mol Med Rep
. 2024 Oct;
30(6).
PMID: 39422033
Anaplastic thyroid cancer (ATC) is one of the deadliest and most aggressive human malignancies for which there is currently no effective treatment. Tyrosine kinase receptor RON is highly expressed in...
3.
Feng Q, Hu K, Hu H, Lu Y, Zhang H, Wang G, et al.
Int Immunopharmacol
. 2024 Jun;
137:112499.
PMID: 38909009
No abstract available.
4.
Song D, Zhang X, Li B, Sun Y, Mei H, Cheng X, et al.
Nano Lett
. 2024 Feb;
24(10):3082-3088.
PMID: 38416583
The translational and rotational dynamics of anisotropic optical nanoprobes revealed in single particle tracking (SPT) experiments offer molecular-level information about cellular activities. Here, we report an automated high-speed multidimensional SPT...
5.
Lai Y, Guo S, Tang Q, Chang G, Zhang H, Li B, et al.
Arch Biochem Biophys
. 2024 Feb;
754:109929.
PMID: 38367794
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Although treatment options have improved, a large proportion of patients show low survival rates, highlighting an urgent...
6.
Zhang H, Hu K, Lu Y, Xu Z, Chen G, Yu D, et al.
Int Immunopharmacol
. 2023 Dec;
127:111446.
PMID: 38157697
Multiple myeloma (MM) is an incurable and recurrent malignancy characterized by abnormal plasma cell proliferation. There is an urgent need to develop effective drugs in MM. DCZ0825 is a small...
7.
Wang Y, Dong S, Hu K, Xu L, Feng Q, Li B, et al.
J Transl Med
. 2023 Nov;
21(1):858.
PMID: 38012658
Background: Multiple myeloma (MM), an incurable disease owing to drug resistance, requires safe and effective therapies. Norcantharidin (NCTD), an active ingredient in traditional Chinese medicines, possesses activity against different cancers....
8.
Jin S, Li B, Zhang B, Gao X, Jia X, Xu L, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2023 Nov;
55(12):1884-1891.
PMID: 38009004
Multiple myeloma (MM) is characterized by excessive aggregation of B-cell-derived malignant plasma cells in the hematopoietic system of bone marrow. Previously, we synthesized an innovative molecule named dihydrocelastrol (DHCE) from...
9.
Chang S, Xiao W, Xie Y, Xu Z, Li B, Wang G, et al.
Cancer Med
. 2023 Nov;
12(23):21321-21334.
PMID: 37942576
Background: Thyroid hormone receptor interacting protein 13 (Trip13) is an AAA-ATPase that regulates the assembly or disassembly protein complexes and mediates Double-strand breaks (DSBs) repair. Overexpression of Trip13 has been...
10.
Feng Q, Hu K, Hu H, Lu Y, Zhang H, Wang G, et al.
Int Immunopharmacol
. 2023 Nov;
125(Pt A):111139.
PMID: 37913572
The most common neoplasm among adult lymphomas is diffuse large B-cell lymphoma (DLBCL), typically characterized by pain-free and progressive lymph node enlargement. Due to high heterogeneity of DLBCL, 30-40 %...